The β1-Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function*. Issue 9 (18th February 2022)
- Record Type:
- Journal Article
- Title:
- The β1-Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function*. Issue 9 (18th February 2022)
- Main Title:
- The β1-Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory Function*
- Authors:
- Durand, Manon
Hagimont, Eugénie
Louis, Huguette
Asfar, Pierre
Frippiat, Jean-Pol
Singer, Mervyn
Gauchotte, Guillaume
Labat, Carlos
Lacolley, Patrick
Levy, Bruno
Glenn Chousterman, Benjamin
Kimmoun, Antoine - Abstract:
- Abstract : OBJECTIVES: Although cardiovascular benefits of β1 -adrenergic receptor blockade have been described in sepsis, little is known about its impact on the adaptive immune response, specifically CD4 T cells. Herein, we study the effects of β1 -adrenergic receptor modulation on CD4 T-cell function in a murine model of sepsis. DESIGN: Experimental study. SETTING: University laboratory. SUBJECTS: C57BL/6 mice. INTERVENTIONS: High-grade sepsis was induced by cecal ligation and puncture in wild-type mice (β1 +/+ ) with or without esmolol (a selective β1 -adrenergic receptor blocker) or in β1 -adrenergic receptor knockout mice (β1 –/– ). At 18 hours after surgery, echocardiography was performed with blood and spleen collected to analyze lymphocyte function. MEASUREMENTS AND MAIN RESULTS: At 18 hours, β1 +/+ cecal ligation and puncture mice exhibited characteristics of high-grade sepsis and three surrogate markers of immunosuppression, namely decreased splenic CD4 T cells, reduced CD4 T-cell proliferation, and increased regulatory T lymphocyte cell proportions. Pharmacologic and genetic β1 -adrenergic receptor blockade reversed the impact of sepsis on CD4 T and regulatory T lymphocyte proportions and maintained CD4 T-cell proliferative capacity. β1 -adrenergic receptor blocked cecal ligation and puncture mice also exhibited a global decrease in both pro- and anti-inflammatory mediators and improved in vivo cardiovascular efficiency with maintained cardiac power index despiteAbstract : OBJECTIVES: Although cardiovascular benefits of β1 -adrenergic receptor blockade have been described in sepsis, little is known about its impact on the adaptive immune response, specifically CD4 T cells. Herein, we study the effects of β1 -adrenergic receptor modulation on CD4 T-cell function in a murine model of sepsis. DESIGN: Experimental study. SETTING: University laboratory. SUBJECTS: C57BL/6 mice. INTERVENTIONS: High-grade sepsis was induced by cecal ligation and puncture in wild-type mice (β1 +/+ ) with or without esmolol (a selective β1 -adrenergic receptor blocker) or in β1 -adrenergic receptor knockout mice (β1 –/– ). At 18 hours after surgery, echocardiography was performed with blood and spleen collected to analyze lymphocyte function. MEASUREMENTS AND MAIN RESULTS: At 18 hours, β1 +/+ cecal ligation and puncture mice exhibited characteristics of high-grade sepsis and three surrogate markers of immunosuppression, namely decreased splenic CD4 T cells, reduced CD4 T-cell proliferation, and increased regulatory T lymphocyte cell proportions. Pharmacologic and genetic β1 -adrenergic receptor blockade reversed the impact of sepsis on CD4 T and regulatory T lymphocyte proportions and maintained CD4 T-cell proliferative capacity. β1 -adrenergic receptor blocked cecal ligation and puncture mice also exhibited a global decrease in both pro- and anti-inflammatory mediators and improved in vivo cardiovascular efficiency with maintained cardiac power index despite the expected decrease in heart rate. CONCLUSIONS: β1 -adrenergic receptor activation enhances regulatory T lymphocyte inhibitory function and thus contributes to sepsis-induced immunosuppression. This can be attenuated by β1 -adrenergic receptor blockade, suggesting a potential immunoregulatory role for this therapy in the management of sepsis. … (more)
- Is Part Of:
- Critical care medicine. Volume 50:Issue 9(2022)
- Journal:
- Critical care medicine
- Issue:
- Volume 50:Issue 9(2022)
- Issue Display:
- Volume 50, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 50
- Issue:
- 9
- Issue Sort Value:
- 2022-0050-0009-0000
- Page Start:
- e707
- Page End:
- e718
- Publication Date:
- 2022-02-18
- Subjects:
- adrenoreceptor -- beta blocker -- lymphocytes -- immunosuppression -- sepsis
Critical care medicine -- Periodicals
Soins intensifs -- Périodiques
616.028 - Journal URLs:
- http://journals.lww.com/ccmjournal/Pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/CCM.0000000000005503 ↗
- Languages:
- English
- ISSNs:
- 0090-3493
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3487.451000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23292.xml